FY2024 EPS Estimates for Henry Schein Reduced by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Leerink Partnrs lowered their FY2024 earnings estimates for shares of Henry Schein in a note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $4.74 for the year, down from their previous estimate of $4.81. The consensus estimate for Henry Schein’s current full-year earnings is $4.78 per share. Leerink Partnrs also issued estimates for Henry Schein’s Q4 2024 earnings at $1.19 EPS, Q1 2025 earnings at $1.19 EPS, Q2 2025 earnings at $1.24 EPS, Q3 2025 earnings at $1.25 EPS, Q4 2025 earnings at $1.32 EPS, FY2025 earnings at $5.00 EPS, FY2026 earnings at $5.57 EPS and FY2027 earnings at $6.19 EPS.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same period last year, the company posted $1.32 EPS.

Several other analysts also recently commented on the stock. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price on the stock. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Jefferies Financial Group lifted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their target price for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Seven equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Stock Performance

Shares of HSIC stock opened at $79.87 on Thursday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.96 billion, a P/E ratio of 32.87, a price-to-earnings-growth ratio of 2.04 and a beta of 0.89. The company’s 50 day moving average price is $73.19 and its two-hundred day moving average price is $71.27. Henry Schein has a 52 week low of $63.67 and a 52 week high of $82.63.

Institutional Trading of Henry Schein

Several institutional investors have recently added to or reduced their stakes in HSIC. FMR LLC boosted its holdings in shares of Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company’s stock worth $239,177,000 after buying an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP boosted its holdings in shares of Henry Schein by 30.0% during the 3rd quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company’s stock worth $189,540,000 after buying an additional 600,000 shares in the last quarter. Nuance Investments LLC boosted its holdings in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock worth $166,072,000 after buying an additional 414,748 shares in the last quarter. Clarkston Capital Partners LLC boosted its holdings in shares of Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock worth $101,900,000 after buying an additional 71,560 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Henry Schein by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company’s stock worth $85,662,000 after buying an additional 6,184 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.